These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Mendrek A; Monterosso J; Simon SL; Jarvik M; Brody A; Olmstead R; Domier CP; Cohen MS; Ernst M; London ED Addict Behav; 2006 May; 31(5):833-44. PubMed ID: 16009504 [TBL] [Abstract][Full Text] [Related]
24. Preliminary effects of progressive muscle relaxation on cigarette craving and withdrawal symptoms in experienced smokers in acute cigarette abstinence: a randomized controlled trial. Limsanon T; Kalayasiri R Behav Ther; 2015 Mar; 46(2):166-76. PubMed ID: 25645166 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal. Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436 [TBL] [Abstract][Full Text] [Related]
26. Smoking behavior and perceived stress in cigarette smokers undergoing elective surgery. Warner DO; Patten CA; Ames SC; Offord K; Schroeder D Anesthesiology; 2004 May; 100(5):1125-37. PubMed ID: 15114209 [TBL] [Abstract][Full Text] [Related]
27. Acute doses of d-amphetamine and bupropion increase cigarette smoking. Cousins MS; Stamat HM; de Wit H Psychopharmacology (Berl); 2001 Sep; 157(3):243-53. PubMed ID: 11605079 [TBL] [Abstract][Full Text] [Related]
28. Negative Urgency Is Associated With Heightened Negative Affect and Urge During Tobacco Abstinence in Regular Smokers. Park AD; Farrahi LN; Pang RD; Guillot CR; Aguirre CG; Leventhal AM J Stud Alcohol Drugs; 2016 Sep; 77(5):766-73. PubMed ID: 27588535 [TBL] [Abstract][Full Text] [Related]
29. The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Froeliger B; McConnell PA; Stankeviciute N; McClure EA; Kalivas PW; Gray KM Drug Alcohol Depend; 2015 Nov; 156():234-242. PubMed ID: 26454838 [TBL] [Abstract][Full Text] [Related]
30. Plasma nicotine, plasma beta-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement. Wewers ME; Tejwani GA; Anderson J Psychopharmacology (Berl); 1994 Sep; 116(1):98-102. PubMed ID: 7862939 [TBL] [Abstract][Full Text] [Related]
31. Does smoking abstinence influence distress tolerance? An experimental study comparing the response to a breath-holding test of smokers under tobacco withdrawal and under nicotine replacement therapy. Cosci F; Anna Aldi G; Nardi AE Psychiatry Res; 2015 Sep; 229(1-2):89-93. PubMed ID: 26233827 [TBL] [Abstract][Full Text] [Related]
32. Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy. Bowen DJ; Spring B; Fox E J Behav Med; 1991 Apr; 14(2):97-110. PubMed ID: 1880796 [TBL] [Abstract][Full Text] [Related]
33. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002 [TBL] [Abstract][Full Text] [Related]
34. Effects of nicotine withdrawal on panic-like response to breath holding: a placebo-controlled, double-blind, crossover patch study. Cosci F; Bertoli G; Abrams K Depress Anxiety; 2013 Dec; 30(12):1217-21. PubMed ID: 23554155 [TBL] [Abstract][Full Text] [Related]
35. Reinforcing value of smoking relative to physical activity and the effects of physical activity on smoking abstinence symptoms among young adults. Audrain-McGovern J; Strasser AA; Ashare R; Wileyto EP Exp Clin Psychopharmacol; 2015 Dec; 23(6):477-85. PubMed ID: 26348158 [TBL] [Abstract][Full Text] [Related]
36. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238 [TBL] [Abstract][Full Text] [Related]
37. Naltrexone alteration of acute smoking response in nicotine-dependent subjects. King AC; Meyer PJ Pharmacol Biochem Behav; 2000 Jul; 66(3):563-72. PubMed ID: 10899371 [TBL] [Abstract][Full Text] [Related]
38. Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement. Dallery J; Raiff BR Psychopharmacology (Berl); 2007 Mar; 190(4):485-96. PubMed ID: 17205320 [TBL] [Abstract][Full Text] [Related]
39. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence. Ray R; Rukstalis M; Jepson C; Strasser A; Patterson F; Lynch K; Lerman C J Psychopharmacol; 2009 Mar; 23(2):168-76. PubMed ID: 18515446 [TBL] [Abstract][Full Text] [Related]
40. Pre-quit depression level and smoking expectancies for mood management predict the nature of smoking withdrawal symptoms in college women smokers. Copeland AL; Kulesza M; Hecht GS Addict Behav; 2009 May; 34(5):481-3. PubMed ID: 19157715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]